Cesca Therapeutics Inc., a Rancho Cordova medical device company, said Friday it is facing possible delisting by Nasdaq because of its low stock price.
Cesca, which makes a variety of diagnostic and medical devices, said it received the notice because it stock price has closed below $1 a share for 30 straight business days.
The company said it has until Sept. 28 to get back into compliance or face delisting. Compliance means the stock must close above $1 for at least 10 straight business days.
If delisted, the company could seek to be traded on a less prominent exchange.
Cesca has faced this problem before. It was threatened with possible delisting in 2009, when it was known as Thermogenesis.